Inactive Instrument

Highlights Metacrine, Inc.

Equities

MTCR

US59101E1038

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Equillium, Metacrine Agree to Terminate Proposed Merger	22-12-27	MT
Metacrine, Equillium Mutually Agree to Terminate Merger Accord	22-12-23	MT
Metacrine and Equillium Mutually Agree to Terminate Definitive Merger Agreement	22-12-23	GL
Metacrine and Equillium Mutually Agree to Terminate Definitive Merger Agreement	22-12-23	AQ
Equillium, Inc. (NasdaqGM:EQ) cancelled the acquisition of Metacrine, Inc. from a group of shareholders.	22-12-22	CI
METACRINE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	22-11-14	AQ
Metacrine, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
METACRINE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Metacrine Inc. - MTCR	22-11-11	PR
Metacrine, Inc. Enters into A License Agreement with FL2022-001, Inc	22-10-11	CI
METACRINE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Metacrine Inc. - MTCR	22-10-04	BU
METACRINE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Metacrine Inc. - MTCR	22-09-07	BU
Equillium to Acquire Biopharmaceutical Company Metacrine in All-Stock Deal	22-09-06	MT
Equillium, Inc. (NasdaqGM:EQ) entered into a definitive merger agreement to acquire Metacrine, Inc. from a group of shareholders.	22-09-05	CI
METACRINE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	22-08-09	AQ
Metacrine, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-09	CI
METACRINE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	22-05-12	AQ
Metacrine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12	CI
METACRINE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	22-03-30	AQ
Metacrine, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-30	CI
Metacrine, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-03-30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Metacrine, Inc.

Equities

MTCR

US59101E1038

Highlights

Filters